Synthetic VLP Vaccines

About nCage Therapeutics

nCage Therapeutics is an early-stage biotech leveraging its proprietary TRAP-cage platform to design synthetic virus-like particles for vaccine and drug delivery applications. The platform's key differentiators include programmable opening/closing for cargo loading and the ability to display biomolecules in precise arrays. The company is advancing preclinical programs in respiratory vaccines and oncology ADCs, supported by strategic collaborations with academia and industry partners like MSD. As a private, pre-revenue entity, nCage is building a foundation of intellectual property and proof-of-concept data to attract further partnership and investment.

Therapeutic Areas

Other Respiratory Diseases Drugs